- Turkish Journal of Medical Sciences
- Vol: 50 Issue: 4
- The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in d...
The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma
Authors : Nazlı Gülsoy Kirnap, Özlem Turhan Iyidir, Yusuf Bozkuş, Şerife Mehlika Işildak, Cüneyd Anil, Sevde Nur Firat, Canan Demir, Aslı Nar, Neslihan Başçil Tütüncü
Pages : 870-876
Doi:10.3906/sag-1902-176
View : 13 | Download : 0
Publication Date : 9999-12-31
Article Type : Makaleler
Abstract :Background/aim: Overt thyroidism is known to cause neuropsychiatric disorders but studies on subclinical hyperthyroidism SCH are limited. Subclinical hyperthyroidism induction by administering L-Thyroxine LT4 is the standard treatment method in differentiated thyroid carcinoma DTC follow-up. Our aim was to investigate whether anxiety, depression and quality of life are affected in DTC patients followed-up with exogenous SCH. Materials and methods: The patients were divided into exogenous SCH by LT4-DTC n = 127 , euthyroid-DTC n = 66 and exogenous euthyroid-benign thyroid noduüle BTN who underwent thyroidectomy for benign thyroid pathology n = 85 groups. Results: The rate of moderate/severe anxiety was significantly higher in SCH-DTC than euthyroid-BTN group 27.5%, n = 35 vs. 9.4%, n = 8 P = 0.001 . TSH levels and Beck anxiety inventory BAI scores were significantly negatively correlated P = 0.009 r = -0.16 . Free T4 and BAI were significantly positively correlated P = 0.04 r = 0.4 . The groups were similar in terms of depression severity P = 0.15 . Subclinical hyperthyroid-DTC group scored significantly lowerthan euthyroid-BTN group in all scales of SF-36 quality of life survey. Conclusion: LT4-induced SCH, which is a part of traditional DTC treatment, can exacerbate the anxiety symptoms in patients and disrupt their quality of life, depending on the level of fT4.Keywords : Beck anxiety and depression inventory, differentiated thyroid carcinoma, SF-36 quality of life survey, subclinical hyperthyroidism, TSH suppression